Annie Killoran

543 total citations
14 papers, 380 citations indexed

About

Annie Killoran is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Annie Killoran has authored 14 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 10 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Annie Killoran's work include Genetic Neurodegenerative Diseases (10 papers), Neurological disorders and treatments (8 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Annie Killoran is often cited by papers focused on Genetic Neurodegenerative Diseases (10 papers), Neurological disorders and treatments (8 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Annie Killoran collaborates with scholars based in United States, Canada and Netherlands. Annie Killoran's co-authors include Kevin Biglan, Amir Abdolahi, E. Ray Dorsey, Jordan L. Schultz, John Kamholz, Peg Nopoulos, Shirley Eberly, Ira Shoulson, Elise Kayson and Joseph Jankovic and has published in prestigious journals such as Neurology, Movement Disorders and Human Gene Therapy.

In The Last Decade

Annie Killoran

14 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Killoran United States 10 206 173 135 40 39 14 380
José Vale Portugal 14 181 0.9× 150 0.9× 133 1.0× 91 2.3× 11 0.3× 35 453
Lorenzo Verriello Italy 12 282 1.4× 151 0.9× 124 0.9× 32 0.8× 20 0.5× 41 430
Ji Seon Kim South Korea 11 241 1.2× 102 0.6× 63 0.5× 42 1.1× 32 0.8× 30 373
Albert Stezin India 11 233 1.1× 109 0.6× 60 0.4× 19 0.5× 46 1.2× 49 364
Thaís Lampert Monte Brazil 14 347 1.7× 324 1.9× 253 1.9× 19 0.5× 34 0.9× 17 521
E Fernández-Álvarez Spain 12 282 1.4× 146 0.8× 89 0.7× 51 1.3× 47 1.2× 41 514
Sean Taylor Canada 11 95 0.5× 84 0.5× 93 0.7× 28 0.7× 105 2.7× 21 341
Ana Lúcia Zuma de Rosso Brazil 14 372 1.8× 123 0.7× 55 0.4× 47 1.2× 85 2.2× 48 533
Hugo Morales‐Briceño Australia 11 234 1.1× 86 0.5× 66 0.5× 19 0.5× 30 0.8× 52 349
J López del Val Spain 11 176 0.9× 101 0.6× 79 0.6× 73 1.8× 28 0.7× 26 347

Countries citing papers authored by Annie Killoran

Since Specialization
Citations

This map shows the geographic impact of Annie Killoran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Killoran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Killoran more than expected).

Fields of papers citing papers by Annie Killoran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Killoran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Killoran. The network helps show where Annie Killoran may publish in the future.

Co-authorship network of co-authors of Annie Killoran

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Killoran. A scholar is included among the top collaborators of Annie Killoran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Killoran. Annie Killoran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Considine, Ciaran, Clare M. Eddy, Samuel Frank, et al.. (2025). Improving the Clinical Diagnostic Criteria for Genetically Confirmed Adult-Onset Huntington Disease. Neurology Clinical Practice. 15(2). e200427–e200427. 2 indexed citations
2.
Killoran, Annie, et al.. (2023). Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis. Parkinsonism & Related Disorders. 119. 105954–105954. 1 indexed citations
3.
Mendez, Aldo A., et al.. (2018). A Fatal Case of Herpes Simplex Encephalitis with Two False-Negative Polymerase Chain Reactions. Case Reports in Neurology. 10(2). 217–222. 11 indexed citations
4.
Schultz, Jordan L., et al.. (2018). Evaluating depression and suicidality in tetrabenazine users with Huntington disease. Neurology. 91(3). e202–e207. 29 indexed citations
5.
Schultz, Jordan L., Peg Nopoulos, Annie Killoran, & John Kamholz. (2018). Statin use and delayed onset of Huntington's disease. Movement Disorders. 34(2). 281–285. 14 indexed citations
6.
Schultz, Jordan L., John Kamholz, Peg Nopoulos, & Annie Killoran. (2018). Comparing Risperidone and Olanzapine to Tetrabenazine for the Management of Chorea in Huntington Disease: An Analysis from the Enroll‐HD Database. Movement Disorders Clinical Practice. 6(2). 132–138. 12 indexed citations
7.
Killoran, Annie. (2016). Biomarkers for Huntington's disease: A brief overview. 1(2). 46–50. 6 indexed citations
8.
Killoran, Annie & Kevin Biglan. (2014). Current therapeutic options for Huntington's disease: Good clinical practice versus evidence‐based approaches?. Movement Disorders. 29(11). 1404–1413. 47 indexed citations
9.
Killoran, Annie, Kevin Biglan, Joseph Jankovic, et al.. (2013). Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology. 80(22). 2022–2027. 63 indexed citations
10.
Killoran, Annie, et al.. (2013). Analysis of Analgesic Use in Pre-Manifest Huntington Disease (P07.208). Neurology. 80(7_supplement). 1 indexed citations
11.
Abdolahi, Amir, et al.. (2012). Potential reliability and validity of a modified version of the Unified Parkinson's Disease Rating Scale that could be administered remotely. Parkinsonism & Related Disorders. 19(2). 218–221. 111 indexed citations
12.
Killoran, Annie & Kevin Biglan. (2012). Therapeutics in Huntington’s Disease. Current Treatment Options in Neurology. 14(2). 137–149. 17 indexed citations
13.
Thompson, Miles D., Annie Killoran, Maire E. Percy, et al.. (2006). Hyperphosphatasia With Neurologic Deficit: A Pyridoxine-Responsive Seizure Disorder?. Pediatric Neurology. 34(4). 303–307. 41 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Vale Breakdown of academic impact, for papers by Lorenzo Verriello Breakdown of academic impact, for papers by Ji Seon Kim Breakdown of academic impact, for papers by Albert Stezin Breakdown of academic impact, for papers by Thaís Lampert Monte Breakdown of academic impact, for papers by E Fernández-Álvarez Breakdown of academic impact, for papers by Sean Taylor Breakdown of academic impact, for papers by Ana Lúcia Zuma de Rosso Breakdown of academic impact, for papers by Hugo Morales‐Briceño Breakdown of academic impact, for papers by J López del Val
Rankless by CCL
2026